Stockscreener 앱 받기
3.65
1.62%
-0.06
시간 외 거래:
3.65
전일 마감가:
$3.71
열려 있는:
$3.69
하루 거래량:
133.98K
Relative Volume:
1.04
시가총액:
$4.62M
수익:
$204.80K
순이익/손실:
$-8.27M
주가수익비율:
-0.4012
EPS:
-9.097
순현금흐름:
$-2.63M
1주 성능:
-4.95%
1개월 성능:
-35.85%
6개월 성능:
-48.74%
1년 성능:
-54.88%
1일 변동 폭
$3.62
$3.91
1주일 범위
$3.40
$3.97
52주 변동 폭
$3.40
$12.05
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
Compare ADXN vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
3.65 | 5.78M | 204.80K | -8.27M | -2.63M | -9.097 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-31 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr 주식(ADXN)의 최신 뉴스
Timothy Mark Dyer Discloses 8.98% Stake in Addex Therapeutics (NASDAQ: ADXN) - Kalkine Media
Addex Therapeutics LtdADR Peer Comparison – Compare with Others - valueresearchonline.com
Addex Therapeutics Ltd Sponsored ADR Revenue Breakdown – MUN:APE1 - TradingView
Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness - Barchart.com
Addex Therapeutics Ltd Sponsored ADR Actuals & Estimates (NASDAQ:ADXN) - TradingView
Enterprise value to revenue forward of Addex Therapeutics Ltd Sponsored ADR – LSX:A3EXC6 - TradingView
Price to earnings forward of Addex Therapeutics Ltd Sponsored ADR – LSX:A3EXC6 - TradingView
Price to sales forward of Addex Therapeutics Ltd Sponsored ADR – LSX:A3EXC6 - TradingView
Earnings call transcript: Addex Therapeutics trims loss in Q1 2026 as cash burn stays low - Investing.com India
Addex Therapeutics Q1 2026 Earnings Call Transcript - MarketBeat
Press Release: Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - Moomoo
Addex Convenes Annual General Meeting 2026 - Barchart.com
ADXN - Finviz
Addex Therapeutics (NASDAQ: ADXN) flags tight cash runway and heavy partner reliance - Stock Titan
Addex Therapeutics H2 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Addex Therapeutics H2 2026 reveals strategic shifts By Investing.com - Investing.com India
Earnings call transcript: Addex Therapeutics H2 2026 reveals strategic shifts - Investing.com
Addex Reports Full Year 2025 Financial Results and Provides Corporate Update - Barchart.com
Addex Therapeutics announces GABAB PAM candidate data - TipRanks
Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model - Barchart.com
Unusual VolumeStock ScreenerNews - Finviz
Addex Therapeutics says spin-out company to complete NTX-253 study in Q2 - TipRanks
Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model - Barchart.com
Addex Therapeutics Short Interest Drops in March - National Today
New HighStock ScreenerSnapshot - Finviz
Top GainersStock ScreenerSnapshot - Finviz
JX Luxventure Group Inc (NASDAQ:JXG) Short Interest Up 140.3% in February - Defense World
Short Interest in Raia Drogasil S.A. (OTCMKTS:RADLY) Increases By 138.8% - Defense World
SPDR SSgA Multi-Asset Real Return ETF (NYSEARCA:RLY) Short Interest Up 142.0% in February - Defense World
Short Interest in Intrum AB (publ) (OTCMKTS:ITJTY) Grows By 140.2% - Defense World
Breakwave Tanker Shipping ETF (NYSEARCA:BWET) Short Interest Update - Defense World
Solidion Technology Inc. (NASDAQ:STI) Sees Significant Growth in Short Interest - Defense World
Addex Therapeutics (NASDAQ:ADXN) Trading 2% Higher – Here’s Why - Defense World
Addex Therapeutics (ADXN) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Addex Therapeutics Earnings Call: Progress Amidst Financial Challenges - The Globe and Mail
Addex Therapeutics Reports Q3 2025 Financial Results - The Globe and Mail
Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Charcot Marie Tooth Disease Market on Track for Major Expansion by 2034, According to DelveInsight | DTx Pharma, Augustine therapeutics, Addex Therapeutics, InFlectis BioScience, Chong Kun Dang pharma - Barchart.com
Addex Therapeutics Reports Significant Loss Amid Financial Challenges - The Globe and Mail
ADXN SEC FilingsAddex Therapeutics Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Addex Therapeutics (ADXN) Trading Halted Due to Volatility | ADX - GuruFocus
Addex Therapeutics Ltd_December 31, 2024 - SEC.gov
Aspire Biopharma (ASBP) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Addex Therapeutics Ltd (ADR) (ADXN) Live Share Price, Invest From India - INDmoney
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Yahoo Finance
Get insights into the top gainers and losers of Monday's pre-market session. - ChartMill
Which stocks are moving after the closing bell on Tuesday? - ChartMill
Addex Therapeutics (ADXN) Stock Forecast and Price Target 2026 - MarketBeat
Barinthus Biotherapeutics plc (BRNS) stock price, news, quote and history - Yahoo Finance UK
Barinthus Biotherapeutics plc (BRNS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Addex Therapeutics Ltd Adr (ADXN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.31%
자본화:
|
볼륨(24시간):